Episode Highlights:
- The industry and operational challenges facing DCT adoption.
- How inconsistent nomenclature has contributed to widespread misunderstanding of DCT, and how misnomers have slowed adoption.
- The challenge of change management and how clarity and infrastructure can be an antidote.
- How DCT can help boost minority representation in clinical trial research, and why shifting those numbers requires time.
- How sponsors can get started with DCT and what they need to consider.
- Why organizational fit is critical and how to assess it.
- Why it’s so important to talk with the patients and understand the challenges they face.
- Why DCT and patient-centric approaches so often go hand-in-hand.
- How patient engagement is changing, and why clinical trials need to adapt to that.
- How sites have been forgotten as stakeholders and why they’re still central to clinical development.
Resources:
